| 3-Dimensional Volumetric Distribution and Dispersion Analysis of the Radioenhancer NBTXR3 in Various Solid Malignancies C Shen, A Ducassou, S Bonvalot, E Chajon, LA Farber, OI Vivar, P Tyan, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), S12-S13, 2022 | | 2022 |
| 489P Analysis of 3-dimensional volumetric distribution and dispersion of the radioenhancer NBTXR3 in various solid malignancies T de Baere, C Shen, A Ducassou, S Bonvalot, E Chajon, L Farber, ... Annals of Oncology 33, S764, 2022 | | 2022 |
| A phase 1 trial of NBTXR3 nanoparticles activated by intensity-modulated radiation therapy (IMRT) in the treatment of advanced-stage head and neck squamous cell carcinoma (HNSCC). C Le Tourneau, V Calugaru, T Jouffroy, J Rodriguez, C Hoffmann, ... Journal of Clinical Oncology 35 (15_suppl), 6080-6080, 2017 | 5 | 2017 |
| A phase I dose expansion study of NBTXR3, radiation enhancing hafnium oxide nanoparticles, for the treatment of cisplatin-ineligible locally advanced HNSCC patients C Le Tourneau, V Calugaru, V Moreno, E Calvo, X Liem, S Salas, ... Journal of Geriatric Oncology 12 (8), S9-S10, 2021 | | 2021 |
| Acellular fish skin matrix on thin-skin graft donor sites: a preliminary study N Badois, P Bauër, M Cheron, C Hoffmann, M Nicodeme, O Choussy, ... Journal of Wound Care 28 (9), 624-628, 2019 | 26 | 2019 |
| Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells P André, C Denis, C Soulas, C Bourbon-Caillet, J Lopez, T Arnoux, ... Cell 175 (7), 1731-1743. e13, 2018 | 984 | 2018 |
| Association of Mycoplasma Hominis and head and neck cancer with unknown primary S Atallah, B Berçot, V Laurence, C Hoffmann European Annals of Otorhinolaryngology, Head and Neck Diseases 137 (1), 69-71, 2020 | 7 | 2020 |
| Bases biologiques de l’immunothérapie anti-cancéreuse V Soumelis, J Medvedovic, C Hoffmann Revue des Maladies Respiratoires Actualités 14 (2), 2S30-2S36, 2022 | | 2022 |
| Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma O Leblanc, S Vacher, C Lecerf, E Jeannot, J Klijanienko, F Berger, ... Cancer Biology & Medicine 17 (1), 208, 2020 | 30 | 2020 |
| Cánceres de la cavidad oral M Menard, J Rodriguez, C Hoffmann, S Hans, A Villeneuve, P Halimi Elsevier Masson, 2018 | | 2018 |
| Cancers de la cavité orale HS Menard M, Rodriguez J, Hoffmann C | | 2018 |
| Cancri della cavità orale M Menard, J Rodriguez, C Hoffmann, S Hans, A Villeneuve, P Halimi EMC-Otorinolaringoiatria 18 (1), 1-24, 2019 | 1 | 2019 |
| Chirurgie transorale assistée par robot en cancérologie des voies aérodigestives supérieures: 100 patients S Hans, C Hoffman, M Ménard, D Brasnu Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale …, 2013 | | 2013 |
| Combination of monalizumab and durvalumab as a potent immunotherapy treatment for solid human cancers C Soulas, R Remark, V Brezar, J Lopez, E Bonnet, F Caraguel, A Lalanne, ... Cancer Research 78 (13_Supplement), 2714-2714, 2018 | 7 | 2018 |
| Combined laser and robotic approach for the management of a mixed laryngomucocele Q Lisan, C Hoffmann, T Jouffroy, S Hans Journal of robotic surgery 10 (1), 81-83, 2016 | 16 | 2016 |
| Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival C Dubot, V Bernard, MP Sablin, S Vacher, W Chemlali, A Schnitzler, ... European Journal of Cancer 91, 47-55, 2018 | 64 | 2018 |
| Contents Vol. 16, 2011 G Muehlmeier, E Biesinger, H Maier, JW Koo, Q Wang, D Bernardeschi, ... Audiology and Neurotology 16 (6), I-IV, 2011 | | 2011 |
| Dendritic Cells in Head and Neck Cancer Microenvironment: From Mechanisms to Biomarkers C Hoffmann Université Paris-Saclay (ComUE), 2019 | | 2019 |
| Early glottic cancer involving the anterior commissure treated by transoral laser cordectomy C Hoffmann, N Cornu, S Hans, B Sadoughi, C Badoual, D Brasnu The Laryngoscope 126 (8), 1817-1822, 2016 | 72 | 2016 |
| Elderly patients with locally advanced head and neck squamous cell carcinoma treated with NBTXR3 nanoparticles activated by radiotherapy: A phase I trial C Le Tourneau, V Calugaru, V Moreno, X Mirabel, B Dodger, E Calvo, ... Annals of Oncology 29, viii377-viii378, 2018 | | 2018 |
